Searching for the 1 in 2,400,000: A review of dystrophin gene point mutations
暂无分享,去创建一个
M Bobrow | M. Bobrow | R. Gardner | R. Roberts | R G Roberts | R J Gardner
[1] A. Speer,et al. Carrier detection in DMD families with point mutations, using PCR-SSCP and direct sequencing , 1994, Neuromuscular Disorders.
[2] J. Mendell,et al. Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection. , 1994, American journal of medical genetics.
[3] N. Laing,et al. Identification of a point mutation and germinal mosaicism in a duchenne muscular dystrophy family , 1994, Human mutation.
[4] Y. Takeshima,et al. A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. , 1994, American journal of human genetics.
[5] O. Ibraghimov-Beskrovnaya,et al. Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin). , 1993, The Journal of biological chemistry.
[6] K. Campbell,et al. Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis. , 1993, Human molecular genetics.
[7] H. Thiele,et al. Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. , 1993, Human molecular genetics.
[8] I. Grunewald,et al. Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene. , 1993, Journal of medical genetics.
[9] J. D. den Dunnen,et al. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. , 1993, Human molecular genetics.
[10] M. Grompe,et al. The rapid detection of unknown mutations in nucleic acids , 1993, Nature genetics.
[11] J. Mendell,et al. A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient , 1993, Nature Genetics.
[12] A. Hamosh,et al. Nonsense mutations and diminished mRNA levels , 1993, Nature Genetics.
[13] N. Laing,et al. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. , 1993, American journal of medical genetics.
[14] C. Mathew,et al. A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. , 1993, Human molecular genetics.
[15] D. Bentley,et al. Exon structure of the human dystrophin gene. , 1993, Genomics.
[16] L. Kunkel,et al. An alternative dystrophin transcript specific to peripheral nerve , 1993, Nature Genetics.
[17] V. Chapman,et al. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin , 1993, Nature Genetics.
[18] Seymour,et al. Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. , 1993, The Journal of clinical investigation.
[19] J. Mendell,et al. Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. , 1993, Human molecular genetics.
[20] L. Maquat,et al. Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA. , 1993, Molecular and cellular biology.
[21] David Valle,et al. The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.
[22] L. Maquat,et al. Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Passos-Bueno,et al. Point mutation in a Becker muscular dystrophy patient. , 1993, Human molecular genetics.
[24] D. Bentley,et al. Infidelity in the structure of ectopic transcripts: A novel exon in lymphocyte dystrophin transcripts , 1993, Human mutation.
[25] L. Morandi,et al. A novel nonsense mutation in the human dystrophin gene , 1993, Human mutation.
[26] J. Mendell,et al. Exon 44 nonsense mutation in two‐duchenne muscular dystrophy brothers detected by heteroduplex analysis , 1993, Human mutation.
[27] A. Hamosh,et al. CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. , 1992, Human molecular genetics.
[28] G. Puca,et al. Detection of a nonsense mutation in the dystrophin gene by multiple SSCP. , 1992, Human molecular genetics.
[29] R. Gibbs,et al. Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient. , 1992, Human molecular genetics.
[30] K. Campbell,et al. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy , 1992, Nature.
[31] C. Caskey,et al. Premature chain termination mutation causing Duchenne muscular dystrophy , 1992, Neurology.
[32] Hideko Yamamoto,et al. Glycoprotein‐binding site of dystrophin is confined to the cysteine‐rich domain and the first half of the carboxy‐terminal domain , 1992, FEBS letters.
[33] G. Danieli,et al. A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. , 1992, Human molecular genetics.
[34] D. Bentley,et al. Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. , 1992, Genomics.
[35] R. Bartlett,et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. , 1992, Genomics.
[36] L. Elsas,et al. Reduced mRNA and a nonsense mutation in the insulin-receptor gene produce heritable severe insulin resistance. , 1992, American journal of human genetics.
[37] K. Davies,et al. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. , 1992, Human molecular genetics.
[38] C. Caskey,et al. Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. , 1992, Nucleic acids research.
[39] S. Baserga,et al. Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Steingrimsdottir,et al. Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. , 1992, Nucleic acids research.
[41] D. Bentley,et al. Point mutations in the dystrophin gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. O’Brien,et al. Detecting single base substitutions as heteroduplex polymorphisms. , 1992, Genomics.
[43] R. Weleber,et al. Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. , 1992, American journal of human genetics.
[44] Jamel Chelly,et al. Illegitimate transcription: Its use in the study of inherited disease , 1992, Human mutation.
[45] A. Wintzen,et al. Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy , 1991, Neuromuscular Disorders.
[46] A. Hamosh,et al. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. , 1991, The Journal of clinical investigation.
[47] S. Burden,et al. Dystrophin is a component of the subsynaptic membrane , 1991, The Journal of cell biology.
[48] R. Gibbs,et al. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. , 1991, American journal of human genetics.
[49] J. Lupski,et al. Is the carboxyl‐terminus of dystrophin required for membrane association? A novel, severe case of duchenne muscular dystrophy , 1991, Annals of neurology.
[50] D. Bentley,et al. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. , 1991, American journal of human genetics.
[51] H Sugita,et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.
[52] D. Bulman,et al. Point mutation in the human dystrophin gene: identification through western blot analysis. , 1991, Genomics.
[53] H. Nishio,et al. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. , 1991, The Journal of clinical investigation.
[54] D. Bentley,et al. Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA , 1990, The Lancet.
[55] A. Chapelle,et al. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies , 1990, Cell.
[56] S. Bar,et al. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. , 1990, The Biochemical journal.
[57] L. Maquat,et al. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA , 1990, Molecular and cellular biology.
[58] K. Davies,et al. Characterization of deletions in the dystrophin gene giving mild phenotypes. , 1990, American journal of medical genetics.
[59] H. Nishio,et al. A very small frame-shifting deletion within exon 19 of the Duchenne muscular dystrophy gene. , 1990, Biochemical and biophysical research communications.
[60] J. Riley,et al. A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. , 1990, Nucleic acids research.
[61] M. W. Thompson,et al. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. , 1990, American journal of human genetics.
[62] L. Kunkel,et al. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.
[63] S. Berget,et al. Exon definition may facilitate splice site selection in RNAs with multiple exons. , 1990, Molecular and cellular biology.
[64] C. van Broeckhoven,et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. , 1989, American journal of human genetics.
[65] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[66] M. Bobrow,et al. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. , 1989, Journal of medical genetics.
[67] M. W. Thompson,et al. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. , 1989, American journal of human genetics.
[68] A. Beaudet,et al. Molecular definition of bovine argininosuccinate synthetase deficiency. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Chasin,et al. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing , 1989, Molecular and cellular biology.
[70] E A Barnard,et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.
[71] G. Sarkar,et al. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. , 1989, Science.
[72] L. Kunkel,et al. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus , 1989, Nature.
[73] J. Concordet,et al. Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[74] D. Bentley,et al. Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy. , 1989, Nucleic acids research.
[75] L. Kunkel,et al. Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. , 1989, The Journal of clinical investigation.
[76] R A Gibbs,et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.
[77] M. W. Thompson,et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. , 1988, Science.
[78] U. Francke,et al. Myopathy in complex glycerol kinase deficiency patients is due to 3' deletions of the dystrophin gene. , 1988, American journal of human genetics.
[79] Jamel Chelly,et al. Transcription of the dystrophin gene in human muscle and non-muscle tissues , 1988, Nature.
[80] R. D. Campbell,et al. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[81] A. Monaco,et al. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.
[82] K. Fischbeck,et al. Duchenne muscular dystrophy gene expression in normal and diseased human muscle. , 1988, Science.
[83] R. Gibbs,et al. Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. , 1988, Science.
[84] A. Monaco,et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.
[85] Marvin B. Shapiro,et al. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.
[86] M. Koenig,et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.